ConductScience.org, home

Paper38332002

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Sake SM and 31 others. Nat Commun, 2024. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Papers, record 38332002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38332002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.
PubMed
Journal
Nat Commun
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
5.98, provisional
iCite
Revised in PubMed
2026-06-04
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sake SMSvenja M
2Zhang XXiaoyu
3Rajak MKManoj Kumar
4Urbanek-Quaing MMelaniehttps://orcid.org/0000-0002-3629-9011
5Carpentier AArnaudhttps://orcid.org/0000-0002-6994-4689
6Gunesch APAntonia P
7Grethe CChristina
8Matthaei AAlina
9Rückert JJessica
10Galloux MMarie
11Larcher TThibauthttps://orcid.org/0000-0002-0396-3190
12Le Goffic RRonanhttps://orcid.org/0000-0002-2012-0064
13Hontonnou FFortune
14Chatterjee AKArnab K
15Johnson KKristenhttps://orcid.org/0000-0003-0788-7217
16Morwood KKaycie
17Rox KKatharinahttps://orcid.org/0000-0002-8020-1384
18Elgaher WAMWalid A Mhttps://orcid.org/0000-0002-8766-4568
19Huang JJiabinhttps://orcid.org/0000-0002-3480-7115
20Wetzke MMartin

Source PubMed

See all 32 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DibenzocycloheptenesMajor topic
PyridinesMajor topic
Respiratory Syncytial Virus InfectionsMajor topic
Animals
Female
Mice
Drug Repositioning
Piperidines
Viral Fusion Proteins

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
EXC 2155 RESIST, Project 390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
EXC 2155 "RESIST" - Project ID 390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
EXC 2155 "RESIST" - Project ID 390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
EXC 2155 "RESIST" - Project ID 390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
EXC 2155 "RESIST" - Project ID 390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
EXC2155 RESIST_390874280Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
INDIRA 11-76251-99-6/19 (ZN3437)Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony)PubMed
OPTIS, Project ID 9B811Volkswagen Foundation (VolkswagenStiftung)PubMed
OPTIS, Project ID 9B811Volkswagen Foundation (VolkswagenStiftung)PubMed
OPTIS, Project ID 9B811Volkswagen Foundation (VolkswagenStiftung)PubMed
OPTIS, ID9B811Volkswagen Foundation (VolkswagenStiftung)PubMed
DZIF, TTU 09.719Deutsches Zentrum für Infektionsforschung (German Center for Infection Research)PubMed
INDIRA 11-76251-99-6/19 (ZN3437)Niedersächsische Ministerium für Wissenschaft und Kultur (Lower Saxony Ministry of Science and Culture)PubMed

Source PubMed

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127839855Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals.Lancet2016https://conductscience.org/library/papers/27839855PubMed
226411809Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics.Lancet Respir Med2015https://conductscience.org/library/papers/26411809PubMed
334725031Non-Appearance of the RSV Season 2020/21 During the COVID-19 Pandemic–Prospective, Multicenter Data on the Incidence of Respiratory Syncytial Virus (RSV) Infection.Dtsch Arztebl Int2021https://conductscience.org/library/papers/34725031PubMed
433817612The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children - A nationwide register study in Finland.EClinicalMedicine2021https://conductscience.org/library/papers/33817612PubMed
536063828
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.
Lancet Infect Dis2023https://conductscience.org/library/papers/36063828PubMed
636463892Decline of RSV-specific antibodies during the COVID-19 pandemic.Lancet Infect Dis2023https://conductscience.org/library/papers/36463892PubMed
736520324Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities.Infect Dis Ther2023https://conductscience.org/library/papers/36520324PubMed
820528472Palivizumab-resistant human respiratory syncytial virus infection in infancy.Clin Infect Dis2010https://conductscience.org/library/papers/20528472PubMed
937749081The road to approved vaccines for respiratory syncytial virus.NPJ Vaccines2023https://conductscience.org/library/papers/37749081PubMed
1030411898State of the Art in Respiratory Syncytial Virus Drug Discovery and Development.J Med Chem2019https://conductscience.org/library/papers/30411898PubMed
1133656652The Future of Respiratory Syncytial Virus Disease Prevention and Treatment.Infect Dis Ther2021https://conductscience.org/library/papers/33656652PubMed
1234234347A condensate-hardening drug blocks RSV replication in vivo.Nature2021https://conductscience.org/library/papers/34234347PubMed
1330282735The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30282735PubMed
1432707573Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.Nature2020https://conductscience.org/library/papers/32707573PubMed
1525140957Oral GS-5806 activity in a respiratory syncytial virus challenge study.N Engl J Med2014https://conductscience.org/library/papers/25140957PubMed
1617576833RSV604, a novel inhibitor of respiratory syncytial virus replication.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17576833PubMed
1730068272Farnesyl Transferase Inhibitors as Potential Anticancer Agents.Mini Rev Med Chem2018https://conductscience.org/library/papers/30068272PubMed
1833590450Lonafarnib: First Approval.Drugs2021https://conductscience.org/library/papers/33590450PubMed
1922046132The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.PLoS Pathog2011https://conductscience.org/library/papers/22046132PubMed
2026719246Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.J Virol2015https://conductscience.org/library/papers/26719246PubMed

See all 62 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42963363Sparfloxacin reveals a host-virus dual-target antiviral scaffold against respiratory syncytial virus.Commun Biol2026https://conductscience.org/library/papers/42963363PubMed
42908255Validation of Small-Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus.ChemMedChem2026https://conductscience.org/library/papers/42908255PubMed
42890265A repurposing screen of 29 media mixtures derived from 15 commercial serum-free media products identifies potential cost reductions for industrial animal cell cultivation.3 Biotech2026https://conductscience.org/library/papers/42890265PubMed
42347671Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.Vaccines (Basel)2026https://conductscience.org/library/papers/42347671PubMed
42210414Renaissance of farnesyltransferase inhibitors in cancer.J Transl Med2026https://conductscience.org/library/papers/42210414PubMed
42197515Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development.Microorganisms2026https://conductscience.org/library/papers/42197515PubMed
42007710Catching our breath: development of interventions and therapies for respiratory syncytial virus.Microbiol Mol Biol Rev2026https://conductscience.org/library/papers/42007710PubMed
41770611FDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine de novo synthesis.Emerg Microbes Infect2026https://conductscience.org/library/papers/41770611PubMed
41576151Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.PLoS Pathog2026https://conductscience.org/library/papers/41576151PubMed
41472282Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach.Viruses2025https://conductscience.org/library/papers/41472282PubMed
41413286β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection.Nat Commun2025https://conductscience.org/library/papers/41413286PubMed
41364004
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
J Virol2026https://conductscience.org/library/papers/41364004PubMed
41327890Mucin-Inspired Filamentous Sulfated Copolymers Effectively Inhibit Human Respiratory Syncytial Virus (hRSV) Infectivity.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41327890PubMed
41030913Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals.MedComm (2020)2025https://conductscience.org/library/papers/41030913PubMed
41026531High-throughput screens identify genotype-specific therapeutics for channelopathies.JCI Insight2025https://conductscience.org/library/papers/41026531PubMed
40848680Status of advanced respiratory syncytial virus antiviral therapeutics 2025.Curr Opin Virol2025https://conductscience.org/library/papers/40848680PubMed
40749064A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo.Sci Adv2025https://conductscience.org/library/papers/40749064PubMed
40486844Advances in development of antiviral strategies against respiratory syncytial virus.Acta Pharm Sin B2025https://conductscience.org/library/papers/40486844PubMed
40316857Cangrelor and AVN-944 as repurposable candidate drugs for hMPV: analysis entailed by AI-driven in silico approach.Mol Divers2025https://conductscience.org/library/papers/40316857PubMed
40016246Rational design of phytovirucide inhibiting nucleocapsid protein aggregation in tomato spotted wilt virus.Nat Commun2025https://conductscience.org/library/papers/40016246PubMed

See all 27 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HSP90AA13320PubTator's text mininghttps://conductscience.org/library/genes/3320

Source NCBI Gene

Download CSV of genes

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
SRASRR22746624-SRR22746626SRA
PDB8PHIPDB

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38332002

GET https://conductscience.org/api/papers/v1/38332002/authors?page=2